CellCentric
Agent34Agent Readiness: 34/100. Below median. Measured by StartupHub.ai. Median 41.Trust79Data Trust: 79/100. Top 25%. Measured by StartupHub.ai. Median 61.A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
About
CellCentric is a clinical-stage biotechnology company focused on developing inobrodib, a novel oral p300/CBP inhibitor, for the treatment of multiple myeloma. The company recently completed an oversubscribed $220 million Series D financing round, which will be used to advance the development of inobrodib.
Listed competitors
Also in this space
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Shares Biotechnology, Drug Discovery
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Therapeutics
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Biotech
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- cellcentric.com
- Headquarters
- Cambridge, England, United Kingdom
- Founded
- 2003
- Employees
- 53
- Total funding
- $375M (Series D)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 6 May 2026 | Series D | $220M | |
| 19 May 2025 | Series C | $120M | RA Capital, Forbion |
| 24 Jul 2024 | Other Equity | $35M |
Tech stack
Detected on cellcentric.com, last scanned 30 Oct 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Barracuda
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is CellCentric trustworthy and reputable?
StartupHub's Data Trust & Reputation score for CellCentric is 79 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has CellCentric raised?
CellCentric has raised a total of $375M in funding. The most recent round on record is Series D.
How many employees does CellCentric have?
CellCentric has approximately 53 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for CellCentric:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
